InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: DewDiligence post# 791

Thursday, 10/25/2018 9:51:27 AM

Thursday, October 25, 2018 9:51:27 AM

Post# of 1169
BMY 3Q18 results:

https://finance.yahoo.com/news/bristol-myers-squibb-reports-third-105900519.html

Worldwide Opdivo sales were $1.79B, +42% YoY.

Worldwide Eliquis sales were $1.58B, +28% YoY.

BMY raised 2018 non-GAAP EPS guidance to $3.80-3.90 (from prior range of $3.55-3.65).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News